The Czech model for preventing heart disease - and what is in it for a student

At the 73rd annual congress of the Israel Heart Society in Tel Aviv, the Czech national heart programme was presented by Prof. Michael Vrablík, chairman of the Czech Society for Atherosclerosis, who led it from the drawing board through to rollout.

It sounds like a subject for doctors only. For a student changing countries it is the opposite: the health system is one of the first things that swaps out from under you, and it is worth understanding how it is built long before you need it.

The numbers behind the programme

Czechia sits in the middle of Europe, and so does its cardiovascular risk profile. Cardiovascular disease accounts for around 42% of all deaths in the country, and in the over-55 age group the prevalence of high blood pressure and high cholesterol reaches almost 90%.

The problem, as the programme frames it, is not a shortage of treatment but the absence of a system: tests done on whoever happened to walk in, results that stay in the lab that ran them, and treatment that begins once the disease is already there.

What the first programme did

The first programme launched in 2013 and went after the acute phase - shortening the road from heart attack to catheterisation lab, and concentrating the work in centres that do enough of it to be good at it. Heart attack mortality fell to about 5.5%, one of the lowest rates in the world.

The machinery it left behind is part of the answer: laboratory data collected centrally, measurable targets, and performance tracked and compared across some 40 cardiovascular centres. What gets measured and compared gets better.

What changed in January 2025

The second programme took effect on 1 January 2025 and moved the target: not lower mortality any more, but a lower disease burden and more healthy years of life. The distinction is not semantic - the average Czech now lives 15 to 20 years with a chronic condition, against roughly three years in the Scandinavian countries. That gap is what the programme is aimed at.

Delivery runs through primary care. The periodic check-up was redesigned to carry a broader cardiovascular risk assessment, and the programme itself was written with more than 20 bodies at the table - professional societies, regulators and payers - partly so that a new drug reaches a patient sooner.

An early sign that it works came from a single test. Once Lp(a) became a fixed part of the check-up, the country’s test kits ran out in week four.

"Prevention happens in decades, not in years," Vrablík said. "If you invest in young people today, you see the results in twenty years."

What it means if you are studying here

The practical part hides in the words "primary care". The whole Czech model rests on a GP you are registered with - that is where the periodic check-up happens, where the data is collected, and where referrals come from. A student who never registers with one is effectively outside the system: A&E will treat you, prevention will not reach you.

Before that comes insurance. EU and EEA students arrive on the European Health Insurance Card, which covers necessary treatment. Students from outside the EU need commercial health insurance as a condition of the long-stay visa or residence permit, and have to produce it again at every renewal.

Both routes rest on the same thing - a registered Czech address. That is why the address is the first step and not the last one.